Delhi HC relief to Intas- stops two pharma companies from violating trademark of LOOZ
The Delhi High Court has permanently restrained two pharmaceutical manufacturers from using the trademark 'LOOZOUT' in their products, which is deceptively similar to the registered trademark 'LOOZ'.
A single bench of Justice Jyoti Singh, while dealing with the suit moved by Intas Pharmaceuticals, also imposed a cost of Rs two lakh to the defendant companies.
As per the recently passed order, apart from permanently restraining them from manufacturing, selling, offering for sale, advertising, and promoting the products using the mark 'LOOZOUT', they are also stopped from manufacturing and selling products under any other mark, which is identical or deceptively similar to the registered mark of the Plaintiff 'LOOZ'.
For more details, check out the full story on the link below:
Delhi HC Relief To Intas- Stops Two Pharma Companies From Violating Trademark Of LOOZ
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.